ABBCI Proton Therapy building exterior

The Penn Medicine Lancaster General Health Ann B. Barshinger Cancer Institute has broken ground on a new state-of-the-art proton therapy facility, becoming the second site in Pennsylvania to offer the innovative radiation therapy to cancer patients.

Construction began in September to add proton therapy to the Cancer Institute’s broad array of radiation-therapy services uniquely offered in a single location by a community hospital. Expected to be completed by Fall 2021, it will be the first and only proton therapy center in Central Pennsylvania.

The Cancer Institute is also expanding the availability of its general research and clinical trials to patients, offering the opportunity to try new and effective treatments that could potentially improve their condition while taking part in vital research that can benefit many future patients.

The Cancer Institute also continues to enhance its personalized medicine services by offering more precision radiation approaches, expanded precision diagnostics, and additional precision treatment and prevention methods.

“The combination goes beyond traditional manners of understanding and responding to disease,” said Randall A. Oyer, MD, Medical Director, Ann B. Barshinger Cancer Institute. “Here, physicians pursue a therapy or treatment protocol based on a patient’s molecular profile, to minimize harmful side effects and to achieve a more successful outcome.”

When it opened in June 2013, part of the Cancer Institute’s vision was to provide a range of services that would offer comprehensive, state-of-the-art compassionate cancer care while minimizing the number of people needing to travel outside Lancaster County for advanced oncology care.

“Today, as part of Penn Medicine, our patients benefit from the collaborative efforts of experts here at the Ann B. Barshinger Cancer Institute and at Penn Medicine’s Abramson Cancer Center—one of the nation’s foremost leaders in cancer research, patient care and education,” said Jan Bergen, President & CEO, LG Health.

Read more about the new proton therapy facility.

Share This Page: